details are here
Encouraging clinical data has been releas... - Cure Parkinson's
Encouraging clinical data has been released by Biovie
Written by
Farooqji
To view profiles and participate in discussions please or .
1 Reply
•
NE3107 Phase 2
6 of 20 receiving treatment experienced morning “on” state with LD withheld overnight compared with 0 for placebo group.
Website prevents copy/ paste of snippets.
Not what you're looking for?
You may also like...
Has anyone been helped by a LSVT global program?
My husband has been diagnosed for 6yrs now. He is 75. His neurologist suggested a physical...
Why has B1 as TTDF been Black-Listed by the Research Community?
*** I ended up with High Blood Pressure taking TTFD. I no longer take TTFD. Based on my experience,...
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107,ERK inhibitor that selectively inhibits neuroinflammation
BioVie announces treatment of 1st patient in Phase 2 clinical trial of NE3107 (an ERK inhibitor...
Well, dementia has been confirmed
Last Monday our specialist confirmed what I had been thinking that my husband has Parkinsons with...
We have been abandoned by Pfizer
Read this:
http://www.newsweek.com/alzheimers-parkinsons-tax-cuts-pfizer-research-780163
It has...
Related Posts
squalamine which has been shown to remove alpha synuclein from the gut and is now in clinical trials for the certain symptoms associated wit
What has been going on with me
Clinical severity in PD is determined by decline in cortical compensation
Has anyone been assessed for PIP?
Encouraging results from the CureParkinsons supported Phase II clinical trial of the GLP-1R agonist Liraglutide
